EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sirtuin 1 is an endogenous NETosis inhibitor that becomes dysfunctional in diabetes

Liang De Wang iD, Feng Chen iD, Rinkoo Dalan, Han Wei Hou, Siu Ling Wong iD

Journal of Leukocyte Biology · 2026

DOI: 10.1093/jleuko/qiag006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2026. Verfasst von Liang De Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, 11 Mandalay Road, Singapore 308232. Hauptthemen laut MEDLINE: Extracellular Traps, Sirtuin 1, Neutrophils, Diabetes Mellitus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nanyang Assistant Professorship, Singapore Ministry of Education under its Singapore Ministry of Education Academic Research Fund Tier 1, Singapore Ministry of Health's National Medical Research Council under its Open Fund-Individual Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neutrophils release their chromatin with toxic granular proteins as neutrophil extracellular traps (NETs) when activated. Diabetes exacerbates NET formation (NETosis), resulting in tissue damage and diabetic complications such as nonhealing wounds. How diabetes predisposes neutrophils to NETosis remains unclear. Herein, we found that pharmacological inhibition or siRNA knockdown of sirtuin 1 (SIRT1) increased NETosis in neutrophils of healthy humans and mice, unveiling SIRT1 as an endogenous suppressor of NETosis. In contrast, SIRT1 inhibition did not cause further increase in NETosis in neutrophils of humans and mice with diabetes, indicative of SIRT1 dysfunction in a disease state. Indeed, SIRT1 deacetylase activity was significantly lower in neutrophils of individuals with diabetes, accompanied by a concomitant increase in the activity of peptidylarginine deiminase 4 (PAD4), a key enzyme that mediates NETosis. PAD4 was codetected with SIRT1 immunoprecipitated from neutrophils isolated from healthy individuals and HL-60–derived neutrophils (dHL-60) cultured in basal glucose; such co-immunoprecipitation was absent in neutrophils of individuals with diabetes and dHL-60 cells treated with high levels of glucose, suggesting that hyperglycemia disrupts the SIRT1–PAD4 interaction. SIRT1 activators restored the SIRT1–PAD4 interaction and normalized the exacerbated NETosis and PAD4 activity in diabetes and hyperglycemia, culminating in improved diabetic wound healing. This study reveals a novel regulatory role of SIRT1 on PAD4 activity. Revitalizing SIRT1 can be a new preventive or therapeutic strategy for combating NET-mediated inflammation in diabetes and beyond.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular TrapsSirtuin 1NeutrophilsDiabetes MellitusHumansAnimalsProtein-Arginine Deiminase Type 4MiceHL-60 CellsMaleProtein-Arginine DeiminasesFemaleMice, Inbred C57BL

Stichwörter der Autor:innen

diabetesneutrophil extracellular trapspeptidylarginine deiminase 4sirtuin 1wound healing

Substanzen

Sirtuin 1Protein-Arginine Deiminase Type 4peptidylarginine deiminase 4, mouseSIRT1 protein, humanPADI4 protein, humanProtein-Arginine Deiminases

Autor:innen und Institutionen

  • Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, 11 Mandalay Road, Singapore 308232.
  • Department of Endocrinology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433.
  • School of Mechanical and Aerospace Engineering, Nanyang Technological University Singapore, 50 Nanyang Avenue, Singapore 639798.
  • Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433.

ORCID-Profile: Liang De Wang, Feng Chen, Siu Ling Wong

Förderung

  • Nanyang Assistant Professorship
  • Singapore Ministry of Education under its Singapore Ministry of Education Academic Research Fund Tier 1
  • Singapore Ministry of Health's National Medical Research Council under its Open Fund-Individual Research Grant
  • Vascular Research Initiative
  • Nanyang President's Graduate Scholarship from Nanyang Technological University Singapore
  • Singapore Ministry of Health's National Medical Research Council under its Open Fund—Individual Research Grant

Zitieren

APA

Wang, L., Chen, F., Dalan, R., Hou, H. W., & Wong, S. L. (2026). Sirtuin 1 is an endogenous NETosis inhibitor that becomes dysfunctional in diabetes. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiag006

Vancouver

Wang L, Chen F, Dalan R, Hou HW, Wong SL. Sirtuin 1 is an endogenous NETosis inhibitor that becomes dysfunctional in diabetes. Journal of Leukocyte Biology. 2026. doi:10.1093/jleuko/qiag006

BibTeX
@article{Wang2026,
  author = {Wang, Liang De and Chen, Feng and Dalan, Rinkoo and Hou, Han Wei and Wong, Siu Ling},
  title = {Sirtuin 1 is an endogenous NETosis inhibitor that becomes dysfunctional in diabetes},
  journal = {Journal of Leukocyte Biology},
  year = {2026},
  doi = {10.1093/jleuko/qiag006}
}
Kostenlos starten →